Overview
- BA.3.2, a highly mutated Omicron-lineage variant with 70 to 75 spike changes, had been reported in at least 23 countries by February 11, 2026, and is now under WHO monitoring.
- CDC tracking shows detections in 25 U.S. states, including 132 wastewater samples, three airplane wastewater finds, and a small number of clinical cases.
- CDC-cited lab data show the 2025–26 LP.8.1 vaccine antigen has the lowest measured antibody neutralization against BA.3.2 among tested variants, which may mean less protection against infection.
- Officials report no signal of increased hospitalizations or deaths and describe symptoms similar to recent Omicron infections, including sore throat, cough, congestion, fatigue, headache, and some gastrointestinal issues.
- Public-health agencies are expanding genomic and wastewater surveillance, which can spot community spread before clinical cases rise, and they urge high-risk people to get vaccinated, test when sick, and consider masks in crowded indoor spaces.